HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vlasta Bradamante Selected Research

Ro 20683

4/2002Adamantyl tenocyclidines--adjuvant therapy in poisoning with organophosphorus compounds and carbamates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vlasta Bradamante Research Topics

Disease

3Body Weight (Weight, Body)
12/2002 - 04/2002
2Hyperlipoproteinemias
01/2007 - 01/2005
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2007 - 01/2005
1Alzheimer Disease (Alzheimer's Disease)
10/2015
1Hypertriglyceridemia
01/2010
1Neoplasms (Cancer)
06/2009
1Poisoning
04/2002

Drug/Important Bio-Agent (IBA)

3LipidsIBA
01/2010 - 01/2005
2Therapeutic UsesIBA
10/2015 - 04/2002
2Simvastatin (Zocor)FDA LinkGeneric
01/2007 - 01/2005
2DichlorvosIBA
12/2002 - 04/2002
1Gemfibrozil (Lopid)FDA LinkGeneric
01/2010
1Pharmaceutical PreparationsIBA
06/2009
1CarcinogensIBA
06/2009
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2009
1Triglycerides (Triacylglycerol)IBA
01/2007
1LDL CholesterolIBA
01/2007
1Lipoproteins (Lipoprotein)IBA
01/2005
1Cycloheximide (Cicloheximide)IBA
09/2002
1ButyrylcholinesteraseIBA
09/2002
1asoxime chloride (H16)IBA
04/2002
1Propoxur (Baygon)IBA
04/2002
1tabunIBA
04/2002
1Organophosphorus CompoundsIBA
04/2002
1OximesIBA
04/2002
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
04/2002
1SomanIBA
04/2002
1Chemical Warfare AgentsIBA
04/2002
1CarbamatesIBA
04/2002
11-(2-(2-thienyl)-2-adamantyl) morpholineIBA
04/2002
1N-Methylaspartate (NMDA)IBA
04/2002
1Aldicarb (Temik)IBA
04/2002
1Ro 20683IBA
04/2002
1AtropineFDA LinkGeneric
04/2002
1InsecticidesIBA
04/2002

Therapy/Procedure

2Therapeutics
01/2005 - 04/2002